Evolus Stock

Evolus Gross Margin

The Gross Margin of Evolus (EOLS) as of Aug 5, 2026 is 64.86 %. In the previous year, Gross Margin was 68.46 % — a change of -5.26% (lower).

Gross Margin

64.86 %

YoY

-5.26%

Last updated:

Gross Margin of Evolus is 2026 64.86 % . Gross Margin of Evolus was 2025 68.46 % . It decreases by -5.26% lower compared to the previous year.

Evolus's gross margin stands at 64.9%, up from 56.3% several years earlier.

Access this data via the Eulerpool API

Evolus Stock analysis

What does Evolus do? Evolus Inc is an innovative biotechnology company based in Irvine, California, specializing in the development and distribution of aesthetic treatments. The company was founded in 2012 and has quickly become a market leader in the industry. Evolus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolus stock

Gross Margin of Evolus is 64.86 % in 2026.

Gross Margin of Evolus changed from 68.46 % to 64.86 %, representing a -5.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Evolus since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Evolus with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — Evolus

All Key Metrics — Evolus